Evidence map›Paper›PMID 41405385›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omics Analysis of 3D Cell Culture Disease Models.

Stefania Alexandra Iakab, Jonas Cordes, Thomas Enzlein, Florian Keller, Kevin Kastner, Theresa Mulholland, Björn Christian Fröhlich, Lars Gruber, James Lucas Cairns, Stefan Schmidt and 7 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Stefania Alexandra IakabCeMOS Research and Transfer Center, Mass Spectrometry and Optical Spectroscopy, Technische Hochschule Mannheim, Paul-Wittsack-Str. 10, 68163, Mannheim, Germany.ORCID https://orcid.org/0000-0002-4156-1942
Jonas CordesCeMOS Research and Transfer Center, Mass Spectrometry and Optical Spectroscopy, Technische Hochschule Mannheim, Paul-Wittsack-Str. 10, 68163, Mannheim, Germany.ORCID https://orcid.org/0000-0003-3148-4282
Thomas EnzleinCeMOS Research and Transfer Center, Mass Spectrometry and Optical Spectroscopy, Technische Hochschule Mannheim, Paul-Wittsack-Str. 10, 68163, Mannheim, Germany.ORCID https://orcid.org/0000-0003-1789-4090
Florian KellerCeMOS Research and Transfer Center, 3D-Models and Imaging, Technische Hochschule Mannheim, Paul-Wittsack-Str. 10, 68163, Mannheim, Germany.
Kevin KastnerCeMOS Research and Transfer Center, Virtual Engineering, Technische Hochschule Mannheim, Paul-Wittsack-Str. 10, 68163, Mannheim, Germany.ORCID https://orcid.org/0000-0002-0180-4727
Theresa MulhollandJunior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-2837-0519
Björn Christian FröhlichCeMOS Research and Transfer Center, Mass Spectrometry and Optical Spectroscopy, Technische Hochschule Mannheim, Paul-Wittsack-Str. 10, 68163, Mannheim, Germany.
Lars GruberCeMOS Research and Transfer Center, Mass Spectrometry and Optical Spectroscopy, Technische Hochschule Mannheim, Paul-Wittsack-Str. 10, 68163, Mannheim, Germany.ORCID https://orcid.org/0009-0009-9955-1550
James Lucas CairnsCeMOS Research and Transfer Center, Mass Spectrometry and Optical Spectroscopy, Technische Hochschule Mannheim, Paul-Wittsack-Str. 10, 68163, Mannheim, Germany.ORCID https://orcid.org/0000-0003-4986-1015
Stefan SchmidtCeMOS Research and Transfer Center, Mass Spectrometry and Optical Spectroscopy, Technische Hochschule Mannheim, Paul-Wittsack-Str. 10, 68163, Mannheim, Germany.
Mathias HafnerCeMOS Research and Transfer Center, 3D-Models and Imaging, Technische Hochschule Mannheim, Paul-Wittsack-Str. 10, 68163, Mannheim, Germany.ORCID https://orcid.org/0000-0001-6222-4219
Richard SchneiderMerck Healthcare KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany.
Johannes BetgeJunior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.ORCID https://orcid.org/0000-0001-9549-1866
Frank FischerMerck KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany.
Julian ReichwaldCeMOS Research and Transfer Center, Virtual Engineering, Technische Hochschule Mannheim, Paul-Wittsack-Str. 10, 68163, Mannheim, Germany.ORCID https://orcid.org/0000-0002-4809-5710
Rüdiger RudolfCeMOS Research and Transfer Center, 3D-Models and Imaging, Technische Hochschule Mannheim, Paul-Wittsack-Str. 10, 68163, Mannheim, Germany.
Carsten HopfCeMOS Research and Transfer Center, Mass Spectrometry and Optical Spectroscopy, Technische Hochschule Mannheim, Paul-Wittsack-Str. 10, 68163, Mannheim, Germany.ORCID https://orcid.org/0000-0003-0802-6451

Funding

BMBF (German Federal Ministry of Research) "Drugs4Future"-12FH8I05IABMBF (German Federal Ministry of Research) "DrugsData"-13FH8I09IABMBF (German Federal Ministry of Research) "M2oga"-03FH8I02IABundesministerium für Bildung und Forschung - MSCorSys SMART-CARE 161L0212FDeutsche Forschungsgemeinschaft 161L0212FDeutsche Forschungsgemeinschaft INST874/9-1Deutsche Forschungsgemeinschaft project No. 497984836
6 · The paper itself

Abstract

Human 3D cell cultures, including spheroids and organoids, are essential biological models for translational pharmaceutical and biomedical research. However, their 3D analysis using 2D- matrix-assisted laser desorption/ionization (MALDI) imaging-based spatial metabolomics remains challenging, since end-to-end solutions for 3D-enabling sample preparation, 3D-data processing, 3D-rendering, and 3D-user interaction are lacking. Here, a 3D-MALDI imaging platform and resource that advances each of three pillars is presented: i) the sample preparation introduces custom-designed molds for precise and reproducible embedding and cryosectioning of multiple spheroids and organoids, a substantial improvement over ad hoc or single-sample sectioning workflows; ii) the integrated computational framework that facilitates the generation of high-fidelity volumetric datasets that enable voxel-based analysis for feature discovery, surpassing traditional slice-based 2D analysis; iii) the mixed reality tool enables immersive spatial exploration of molecular distributions in 3D, extending user engagement beyond static 3D renderings. The versatility of the platform is illustrated by its translation to a clinical framework for the molecular profiling of patient-derived colon cancer organoids. Collectively, this integrated approach enables spatial metabolomic analysis in 3D, offers increased throughput, and paves the way for next-generation molecular diagnostics and personalized medicine applications.

Indexed as

Cell Culture Techniques, Three DimensionalImaging, Three-DimensionalMetabolomicsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationHumansOrganoidsSpheroids, CellularTranslational Research, Biomedical3D reconstructioncancer researchmass spectrometry imagingpatient‐derived organoidpharmaceutical R&Dtranslational clinical research

Identifiers

PMID41405385
PMCPMC12948209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.